OK HB1948

Amends Oklahoma's controlled dangerous substances law to make language gender neutral and prohibit the Director of the Oklahoma State Bureau of Narcotics and Dangerous Drugs Control from assessing administrative fines for violations of central repository access requirements.

Requires registrants or their staff to access the central repository prior to prescribing or refilling opiates, synthetic opiates, semisynthetic opiates, benzodiazepines, or carisoprodol if 180 days have elapsed since the previous check, with exceptions for hospice/end-of-life care and nursing facility prescriptions.

Expands access to the central repository to include medical practitioners employed by federal agencies treating patients in Oklahoma and permits registrants to access information for patient treatment and screening purposes.

Requires registrants or staff to document in patient files that the central repository has been checked and grants registrants immunity from liability for damages resulting from accessing or failing to access the repository.

Establishes that state licensing boards have exclusive enforcement responsibility for central repository access violations and directs the Bureau to provide monthly lists of top twenty controlled substance prescribers to respective licensing boards; effective November 1, 2015.